Dynamics of HBV cccDNA expression and transcription in different cell growth phase

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Chong, Chin Liew ^a,b   Chen, Mong Liang ^c   Wu, Yi Chieh ^b   Tsai, Kuen Nan ^b,d   Huang, Chien Chiao ^a,b   Hu, Cheng Po ^e   Jeng, King Song ^f   Chou, Yu Chi ^f   Chang, Chungming ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^e TUNGHAI UNIVERSITY   (Taiwan)

^f INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

Author keywords

cccDNA; cell proliferation; growth confluency; HBV; viral replication

Indexed keywords

DNA; EXTRACHROMOSOMAL DNA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; LAMIVUDINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PLASMID DNA; CIRCULAR DNA; VIRUS DNA;

ARTICLE; CELL DIVISION; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DYNAMICS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GROWTH CURVE; HEPATITIS B VIRUS; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS NUCLEOCAPSID; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION; DNA REPLICATION; GENETICS; METABOLISM; PLASMID;

HEPATITIS B VIRUS;

CELL PROLIFERATION; DNA REPLICATION; DNA, CIRCULAR; DNA, VIRAL; HEPATITIS B VIRUS; PLASMIDS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 84855170717     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-96     Document Type: Article

References (45)

1. Global control of hepatitis B virus infection. Kao JH, Chen DS, Lancet Infect Dis 2002 2 395 403
2. Hepatitis B virus infection. Dienstag JL, N Engl J Med 2008 359 1486 1500
3. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Tuttleman JS, Pourcel C, Summers J, Cell 1986 47 451 460 (Pubitemid 17210159)
4. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. Sells MA, Zelent AZ, Shvartsman M, Acs G, J Virol 1988 62 2836 2844
5. Hepatitis B virus biology. Seeger C, Mason WS, Microbiol Mol Biol Rev 2000 64 51 68 (Pubitemid 30143840)
6. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Wu TT, Coates L, Aldrich CE, Summers J, Mason WS, Virology 1990 175 255 261 (Pubitemid 20093081)
7. A preliminary trial of lamivudine for chronic hepatitis B infection. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M, N Engl J Med 1995 333 1657 1661 (Pubitemid 26001954)
8. Viral dynamics in hepatitis B virus infection. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H, Proc Natl Acad Sci USA 1996 93 4398 4402 (Pubitemid 26144299)
9. Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment. Abdelhamed AM, Kelley CM, Miller TG, Furman PA, Isom HC, J Virol 2002 76 8148 8160 (Pubitemid 34809069)
10. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. Zhu Y, Yamamoto T, Cullen J, Saputelli J, Aldrich CE, Miller DS, Litwin S, Furman PA, Jilbert AR, Mason WS, J Virol 2001 75 311 322
11. Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. Addison WR, Walters KA, Wong WW, Wilson JS, Madej D, Jewell LD, Tyrrell DL, J Virol 2002 76 6356 6363 (Pubitemid 34556330)
12. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Wieland SF, Spangenberg HC, Thimme R, Purcell RH, Chisari FV, Proc Natl Acad Sci USA 2004 101 2129 2134 (Pubitemid 38229026)
13. Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA. Chou YC, Chen ML, Hu CP, Chen YL, Chong CL, Tsai YL, Liu TL, Jeng KS, Chang C, Hepatology 2007 46 672 681 (Pubitemid 47436112)
14. HBV replication is significantly reduced by IL-6. Kuo TM, Hu CP, Chen YL, Hong MH, Jeng KS, Liang CC, Chen ML, Chang C, J Biomed Sci 2009 16 41
15. Control of cccDNA function in hepatitis B virus infection. Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M, J Hepatol 2009 51 581 592
16. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice. Lutgehetmann M, Volz T, Kopke A, Broja T, Tigges E, Lohse AW, Fuchs E, Murray JM, Petersen J, Dandri M, Hepatology 52 16 24
17. Sequences of hepatitis B virus DNA in the serum and liver of patients with acute benign and fulminant hepatitis. Lugassy C, Bernuau J, Thiers V, Krosgaard K, Degott C, Wantzin P, Schalm SW, Rueff B, Benhamou JP, Tiollais P, et al. J Infect Dis 1987 155 64 71 (Pubitemid 17225084)
18. Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hsu HY, Chang MH, Hsieh KH, Lee CY, Lin HH, Hwang LH, Chen PJ, Chen DS, Hepatology 1992 15 770 776
19. The relationship between differentiation and proliferation in late gestation fetal rat hepatocytes. Gruppuso PA, Bienieki TC, Faris RA, Pediatr Res 1999 46 14 19 (Pubitemid 29293890)
20. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Sureau C, Romet-Lemonne JL, Mullins JI, Essex M, Cell 1986 47 37 47 (Pubitemid 17181531)
21. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells. Huang YQ, Wang LW, Yan SN, Gong ZJ, Hepatobiliary Pancreat Dis Int 2004 3 543 547
22. Effect of hepatocyte proliferation and cellular DNA synthesis on hepatitis B virus replication. Ozer A, Khaoustov VI, Mearns M, Lewis DE, Genta RM, Darlington GJ, Yoffe B, Gastroenterology 1996 110 1519 1528 (Pubitemid 26134086)
23. Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method. Chou YC, Jeng KS, Chen ML, Liu HH, Liu TL, Chen YL, Liu YC, Hu CP, Chang C, J Virol 2005 79 1813 1823 (Pubitemid 40459126)
24. Two regions of an avian hepadnavirus RNA pregenome are required in cis for encapsidation. Calvert J, Summers J, J Virol 1994 68 2084 2090 (Pubitemid 24091884)
25. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. Biermer M, Puro R, Schneider RJ, J Virol 2003 77 4033 4042 (Pubitemid 36350944)
26. Regulatory elements of hepatitis B virus transcription. Moolla N, Kew M, Arbuthnot P, J Viral Hepat 2002 9 323 331
27. Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Schrem H, Klempnauer J, Borlak J, Pharmacol Rev 2004 56 291 330 (Pubitemid 38720832)
28. Expression of HNFs and C/EBP alpha is correlated with immunocytochemical differentiation of cell lines derived from human hepatocellular carcinomas, hepatoblastomas and immortalized hepatocytes. Ishiyama T, Kano J, Minami Y, Iijima T, Morishita Y, Noguchi M, Cancer Sci 2003 94 757 763 (Pubitemid 37258772)
29. Liver-enriched transcription factors and hepatocyte differentiation. Cereghini S, FASEB J 1996 10 267 282 (Pubitemid 26079946)
30. Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Schrem H, Klempnauer J, Borlak J, Pharmacol Rev 2002 54 129 158 (Pubitemid 34208830)
31. Augmentation of urea-synthetic capacity by inhibition of nitric oxide synthesis in butyrate-induced differentiated human hepatocytes. Yoon JH, Lee HS, Kim TH, Woo GH, Kim CY, FEBS Lett 2000 474 175 178 (Pubitemid 30330829)
32. Reversible tumorigenesis by MYC in hematopoietic lineages. Felsher DW, Bishop JM, Mol Cell 1999 4 199 207 (Pubitemid 29456888)
33. Histone deacetylases (HDACs): characterization of the classical HDAC family. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB, Biochem J 2003 370 737 749 (Pubitemid 36399066)
34. G1 phase dependent nuclear localization of relaxed-circular hepatitis B virus DNA and aphidicolin-induced accumulation of covalently closed circular DNA. Yeh CT, Chiu HT, Chu CM, Liaw YF, J Med Virol 1998 55 42 50
35. n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes. Turin F, Borel C, Benchaib M, Kay A, Jamard C, Guguen-Guillouzo C, Trepo C, Hantz O, J Virol 1996 70 2691 2696 (Pubitemid 26121883)
36. Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Tang H, McLachlan A, Proc Natl Acad Sci USA 2001 98 1841 1846 (Pubitemid 32165585)
37. Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. Choi BH, Park GT, Rho HM, J Biol Chem 1999 274 2858 2865 (Pubitemid 29075370)
38. Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II. Ishida H, Ueda K, Ohkawa K, Kanazawa Y, Hosui A, Nakanishi F, Mita E, Kasahara A, Sasaki Y, Hori M, Hayashi N, J Virol 2000 74 1241 1251 (Pubitemid 30044073)
39. Replication of duck hepatitis B virus in primary duck hepatocytes and its dependence on the state of differentiation of the host cell. Galle PR, Schlicht HJ, Kuhn C, Schaller H, Hepatology 1989 10 459 465 (Pubitemid 19255466)
40. Optimised conditions for the production of hepatitis B virus from cell culture. Glebe D, Berting A, Broehl S, Naumann H, Schuster R, Fiedler N, Tolle TK, Nitsche S, Seifer M, Gerlich WH, Schaefer S, Intervirology 2001 44 370 378 (Pubitemid 34114188)
41. Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein. Gao W, Hu J, J Virol 2007 81 6164 6174 (Pubitemid 46878023)
42. Estimating the instability parameters of plasmid-bearing cells. I. Chemostat culture. Ganusov VV, Brilkov AV, J Theor Biol 2002 219 193 205 (Pubitemid 35333806)
43. Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Jang JH, Rives CB, Shea LD, Mol Ther 2005 12 475 483 (Pubitemid 41150133)
44. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. Wong DK, Yuen MF, Poon RT, Yuen JC, Fung J, Lai CL, J Hepatol 2006 45 553 559 (Pubitemid 44307384)
45. The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures. Civitico GM, Locarnini SA, Virology 1994 203 81 89 (Pubitemid 24260024)